A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(6 sites)

South Korea

Pusan National University Hospital, Busan

CHA Bundang Medical Center, Gyeonggi-do

Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do

Soonchunhyang University Cheonan Hospital, Gyeonggi-do

Inha University Hospital, Incheon

Gangnam Severance Hospital, Seoul